Enhancement of protective immune responses induced by Toxoplasma gondii dense granule antigen 7 (GRA7) against toxoplasmosis in mice using a prime-boost vaccination strategy
Authors:
- Daofeng QuDQDaofeng Qu
- Changzheng LiCLChangzheng Li
- Xilin SongXSXilin Song
- Qunli ZhaoQZQunli Zhao
- Xin-Ai LiXLXin-Ai Li
- Yongmei YangYYYongmei Yang
- Qi LiuQLQi Liu
- Shenyi HeShenyi He
- Huaiyu ZhouHZHuaiyu Zhou
Abstract
No abstract availableKeywords
Funding Information
- Outstanding Young Scientists Research Award Project of Shandong, China (BS2009SW008)
- Fund Project of Medicine and Health Development Plan of Shandong, China (2005HZ028)
- National Natural Science Foundation of China (81071373)
This publication has 32 references indexed in Scilit:
- Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccinesMicrobial Cell Factories, 2011
- Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in miceBMC Biotechnology, 2010
- Functional characterization of in vivo effector CD4+ and CD8+ T cell responses in acute Toxoplasmosis: An interplay of IFN-γ and cytolytic T cellsVaccine, 2010
- Toxoplasmosis: A history of clinical observationsInternational Journal for Parasitology, 2009
- GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondiiParasite Immunology, 2007
- A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical TrialClinical and Vaccine Immunology, 2006
- Seroreactivity to and Avidity for Recombinant Antigens in ToxoplasmosisClinical and Vaccine Immunology, 2005
- Vaccination protects B cell-deficient mice against an oral challenge with mildly virulent Toxoplasma gondiiVaccine, 2004
- Recombinant feline herpesvirus type 1 expressing Toxoplasma gondii ROP2 antigen inducible protective immunity in catsParasitology Research, 2002
- Toxoplasmosis: the first commercial vaccineParasitology Today, 1993